Three patients with chronic obstructive pulmonary disease developed coexisting Mycobacterium malmoense and aspergillus infection. All suffered progressive lung destruction leading to early death despite prolonged antimycobacterial chemotherapy. (Thorax 1994;49:521-522) 
1)).
She had a low grade pyrexia and the chest radiograph showed cavitation in both upper lobes. Sputum was film negative for AAFB but the culture was reported positive for M malmoense three months later. Initially she was treated with triple antituberculous chemotherapy (rifampicin, isoniazid, and ethambutol) but subsequently received rifampicin and ethambutol (table). Radiographic and clinical deterioration occurred in September 1990 and isoniazid was reintroduced and the dose of ethambutol increased with no objective response. In March 1991 triple therapy was discontinued because of gastrointestinal symptoms and abnormal liver function tests and treatment with ciprofloxacin was started. Sputum became positive for A fumigatus and precipitating antibodies were detected in the serum for the first time. The patient died in April 1991. Post mortem examination showed gross destruction of both upper lobes and left lower lobe pneumonia in addition to changes consistent with chronic obstructive pulmonary disease. Lung tissue was film positive but culture negative for AAFB and culture positive for A fumigatus. intolerance and clinical and radiographic deterioration, treatment was changed to rifampicin, ethambutol, streptomycin, and ciprofloxacin ( blood vessels but specimens from both upper lobe cavities revealed fungal hyphae on direct microscopy and cultures grew A fumigatus. All specimens were film and culture negative for AAFB. Achromobacter xylosoxidans was cultured from lung, kidney, and spleen.
Discussion
There has been an increase in the incidence of pulmonary M malmoense infection in the UK since 1980 which cannot be attributed to improved culture techniques alone.' Coexistence of M malmoense and aspergillus infection has not been reported previously although M tuberculosis, M xenopi, and M kansasii infections are known to occur in patients with aspergillomata. In contrast, our patients developed aspergillus infection soon (5-22 months) after isolation of M malmoense and all died within eight months of aspergillus colonisation. All patients had evidence of active M malmoense infection rather than colonisation of pre-existing damaged pulmonary tissue. There was radiographic improvement with antimycobacterial treatment in only one patient (case 1) but sputum cultures remained positive for M malmoense. In cases 2 and 3 deterioration occurred in spite of treatment, and all three patients declined rapidly after A fumigatus was isolated. In no patient, however, was there proof of invasive aspergillosis at post mortem examination, this diagnosis being suspected before death in cases 2 and 3. One patient may have been immunocompromised because of long term treatment with prednisolone 5 mg daily. None of the patients had any risk factors for HIV infection. Case 3 consented as part of a research study to an HIV test which was negative.
We suggest that the combination of pulmonary non-tuberculous mycobacterial infection and A fumigatus may have a poorer prognosis than pulmonary mycobacteriosis alone. In the light of our experience with these three cases it may be prudent to treat A fumigatus infection aggressively whenever it is found to complicate non-tuberculous mycobacterial infections. 
